66 related articles for article (PubMed ID: 28881766)
1. NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.
Zhang X; Kang T; Zhang L; Tong Y; Ding W; Chen S
Oncotarget; 2017 Aug; 8(32):52735-52745. PubMed ID: 28881766
[TBL] [Abstract][Full Text] [Related]
2. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
3. Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Ding W; Tong Y; Zhang X; Pan M; Chen S
Sci Rep; 2016 Jan; 6():19793. PubMed ID: 26795951
[TBL] [Abstract][Full Text] [Related]
4. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
[TBL] [Abstract][Full Text] [Related]
5. Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells.
Kang T; Ge M; Wang R; Tan Z; Zhang X; Zhu C; Liu H; Chen S
J Exp Clin Cancer Res; 2019 Dec; 38(1):487. PubMed ID: 31822296
[TBL] [Abstract][Full Text] [Related]
6. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Zhang L; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5851-62. PubMed ID: 26586936
[TBL] [Abstract][Full Text] [Related]
7. Arsenic sulfide as a potential anti‑cancer drug.
Ding W; Zhang L; Kim S; Tian W; Tong Y; Liu J; Ma Y; Chen S
Mol Med Rep; 2015 Feb; 11(2):968-74. PubMed ID: 25371265
[TBL] [Abstract][Full Text] [Related]
8. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
[TBL] [Abstract][Full Text] [Related]
9. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
10. The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28.
Wei Z; Liang L; Junsong L; Rui C; Shuai C; Guanglin Q; Shicai H; Zexing W; Jin W; Xiangming C; Shufeng W
J Exp Clin Cancer Res; 2015 Jun; 34(1):64. PubMed ID: 26084465
[TBL] [Abstract][Full Text] [Related]
11. Regulation of different human NFAT isoforms by neuronal activity.
Vihma H; Luhakooder M; Pruunsild P; Timmusk T
J Neurochem; 2016 May; 137(3):394-408. PubMed ID: 26851544
[TBL] [Abstract][Full Text] [Related]
12. [Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines].
Yu LF; Zhu YB; Qiao MM; Zhong J; Tu SP; Wu YL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2064-9. PubMed ID: 15730617
[TBL] [Abstract][Full Text] [Related]
13. NFATc3 and NFATc4 are required for cardiac development and mitochondrial function.
Bushdid PB; Osinska H; Waclaw RR; Molkentin JD; Yutzey KE
Circ Res; 2003 Jun; 92(12):1305-13. PubMed ID: 12750314
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between urokinase-type plasminogen activator expression and peritoneal metastatic potency in different gastric cancer cell lines].
Ding YC; Zhu ZG; Liu BY; Ji YB; Chen XH; Zhang Y; Yu YY; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):249-51. PubMed ID: 16167240
[TBL] [Abstract][Full Text] [Related]
15. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
[TBL] [Abstract][Full Text] [Related]
16. NFAT as a Biomarker and Therapeutic Target in Non-Small Cell Lung Cancer-Related Brain Metastasis.
Peng L; Tao Y; Wu R; Su J; Sun M; Cheng Y; Xie Z; Mao J; Zhan X; Liu G
Front Oncol; 2021; 11():781150. PubMed ID: 34917508
[TBL] [Abstract][Full Text] [Related]
17. Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines.
Li Q; Yu YY; Zhu ZG; Ji YB; Zhang Y; Liu BY; Chen XH; Lin YZ
Eur Surg Res; 2005; 37(2):105-10. PubMed ID: 15905616
[TBL] [Abstract][Full Text] [Related]
18. Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
He P; Liu Y; Qi J; Zhu H; Wang Y; Zhao J; Cheng X; Wang C; Zhang M
Int J Oncol; 2015 Dec; 47(6):2286-95. PubMed ID: 26498315
[TBL] [Abstract][Full Text] [Related]
19. Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Zhao Y; Wen G; Qiao Z; Xu H; Sun Q; Huang H; Shan S; Mu Z; Zhang J
Lupus; 2013 Apr; 22(5):469-76. PubMed ID: 23554035
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
